1,051 followers
Inotuzumab Ozogamicin: A Review in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukaemia. https://t.co/pSpnfJMmlK https://t.co/rRCMLHWCNr
Inotuzumab Ozogamicin: A Review in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukaemia. https://t.co/pSpnfJMmlK https://t.co/rRCMLHWCNr
Our latest @AdisJournals Drug Evaluation on Inotuzumab Ozogamicin in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukaemia https://t.co/U00K9VjcE2